• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite

    IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System

    Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development

    Iterative Scopes Announces IBD-Focused Scientific Advisory Board

    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Qosina Corp.

    maxon

    Trademark Plastics Inc.

    PTI Engineered Plastics Inc.

    Unicep
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model

    Digital Transformation for Quality and Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    MW Life Sciences

    Medicoil

    Creganna Medical, part of TE Connectivity

    maxon

    PTI Engineered Plastics Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Neurolief Receives CE Mark for Relivion

    Personalized brain neuromodulation technology provides relief from debilitating migraine symptoms.

    Neurolief Receives CE Mark for Relivion
    The Relivion non-invasive, adaptive digital treatment for migraine. Image courtesy of Neurolief Ltd.
    Related CONTENT
    • Connecting the Dots in Medical Device Outsourcing
    • Cantel to Buy Dental Manufacturer Hu-Friedy
    • Hemovent Receives CE Marking for MOBYBOX ECLS System
    • First Non-Invasive, Adaptive Neuromodulation Digital Migraine Treatment Gains CE Mark
    • Tekni-Plex Purchases Manufacturer Lameplast
    Business Wire08.28.19
    Neurolief, a developer of next-generation digital therapeutics brain neuromodulation technology, has received the CE Mark for its Relivion non-invasive, adaptive digital treatment for migraine. The CE mark allows Neurolief to market, sell and distribute the Relivion device as an over-the-counter therapy within the European Union and countries that participate with agreements on Mutual Recognition of Conformity Assessment.
     
    The Relivion is the first non-invasive, adaptive multi-channel brain neuromodulation technology that offers a highly effective therapy, without the risks and costs associated with invasive procedures and without the side effects related to medications. This type of therapy was previously possible only with implanted devices. The Relivion system is simple and safe for patients to self-administer at home at a fraction of the cost of surgical implants.
     
    Neurolief’s Relivion is comprised of a comfortable and adjustable headset that provides precise modulated pulses simultaneously to six branches of the occipital and trigeminal nerves via several adaptive output channels around the patient’s head. The sophisticated cloud-enabled device connects to a proprietary mobile phone app and learns over time to deliver personalized treatment for each patient.
     
    "I believe that the Relivion device from Neurolief has great potential to improve acute migraine therapy," said Alan Rapoport, M.D., clinical professor of neurology at The David Geffen School of Medicine at UCLA (Los Angeles), past president of the International Headache Society (IHS), and the founder and director-emeritus of The New England Center for Headache, in Stamford, Conn. "Not only is it designed to stimulate both the trigeminal and occipital nerves simultaneously to help alleviate migraine without having to worry about side effects from medications, but it does so via a comfortable headset that is different from anything available today. These attributes combine to offer a therapy that migraine sufferers can feel good about using and in turn receive consistent treatment to help them live a more disability-free, productive, fulfilling life."
     
    “This CE mark for the Relivion system marks a vital step in providing patients with alternative, non-drug technology-driven treatments,” said Shmuel Shany, co-founder and CEO, Neurolief. “We designed the Relivion to be a self-administered, safe and attainable alternative to high-cost and high-risk surgical implants, accelerating migraine relief for migraine sufferers in a non-invasive manner. We believe the Relivion will be instrumental in giving patients more rapid relief, increased productivity, and the ability to get back to their lives.”
     
    The CE mark was granted based on data from a randomized, double-blind, placebo-controlled clinical trial which showed very high efficacy and safety of the Relivion in treatment of migraine headache. Seventy-six percent of the participants achieved headache relief after only one treatment while no serious adverse effect were observed.
     
    “Clinical data demonstrate that the Relivion’s confined, closed-loop, interchangeable multi-channel neuromodulation results in a better outcome compared to single-nerve neuromodulation,” said Dr. Eran Schenker, Neurolief’s chief medical innovation officer. “We hypothesize that the disruptive technology synergistic neuromodulatory effect elicited by concurrent activation of both the occipital and trigeminal neural pathways contributes to the superior therapeutic results shown.”
     
    Amit Dar, Neurolief’s co-founder and chief technology officer, added, “Future generations of Neurolief’s innovative technology will include embedded AI and machine learning algorithms, which will provide powerful capabilities to analyze the data collected from each user and from multiple users along with accurate migraine prediction. This will integrate in a seamless fashion to enable updates of the closed-loop personalized brain neuromodulation treatment that improves over time, providing a tailored, precise treatment for each patient. Furthermore, Neurolief is advancing toward implementation of its groundbreaking technology for additional neurological and neuropsychiatric disorders with great unmet need such as major depression.”
     
    Migraine is a prevalent and debilitating primary headache disorder that affects approximately 12 percent of the population worldwide. The World Health Organization (WHO) estimates that 324 million people worldwide suffer from migraines. It is the most prevalent pain condition, prompting loss of productivity with an estimated economic annual burden of over 27 billion euros in European Union countries.1 The economic burden of migraine in the United States was estimated at $36 billion in 2016.2 Migraine patients suffer from disabling symptoms that usually consist of a moderate to severe headache lasting four to 72 hours, nausea and/or vomiting, phonophobia (intolerance to noise) and photophobia (intolerance to light). Seventy-five percent have a reduced ability to function during the migraine episodes, and 33 percent require bed rest during their attacks.3 There is currently no cure for migraines, and over-the-counter medications often do not work. Patients with migraine are often refractory to medical treatment, and some of the most effective antimigraine drugs such as Triptans have substantial side effects.4
     
    Neurolief develops proprietary digital therapeutics brain neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression. The company’s devices either complement or provide an alternative to pharmaceutical therapies, which are often associated with potential short- and long-term adverse effects. Neurolief’s products are groundbreaking electronic headsets designed to concurrently neuromodulate major neural pathways in the head and thereby affect brain regions that are involved in control and modulation of pain and mood. The devices are intended to provide a highly effective, safe and side effect-free treatment for the hundreds of millions of patients worldwide. Future indications for Neurolief’s technology include depression, insomnia, ADHD and additional chronic pain and neuropsychiatric disorders.

    References
    1 Stovener, Lars J, and Andrée, Colette, Impact of headache in Europe: A review for the Eurolight project. The Journal of Headache and Pain, 2008. https://www.researchgate.net/publication/5433227
    2 Bonafede, M., et al., Study Summary: Costs Associated With Migraine in the United States. AJCM, 2018. https://www.ajmc.com/compendium/migraine/study-summary-costs-associated-with-migraine-in-the-united-states
    3 Lipton, R.B., et al., Migraine prevalence, disease burden, and the need for preventive therapy. Neurology, 2007. 68(5): p. 343-9.
    4 Loder, E., Triptan therapy in migraine. New England Journal of Medicine, 2010. 363(1): p. 63-70.
     
    Related Searches
    • safety
    • therapy
    • mobile
    • assessment
    Suggested For You
    Connecting the Dots in Medical Device Outsourcing Connecting the Dots in Medical Device Outsourcing
    Cantel to Buy Dental Manufacturer Hu-Friedy Cantel to Buy Dental Manufacturer Hu-Friedy
    Hemovent Receives CE Marking for MOBYBOX ECLS System Hemovent Receives CE Marking for MOBYBOX ECLS System
    First Non-Invasive, Adaptive Neuromodulation Digital Migraine Treatment Gains CE Mark First Non-Invasive, Adaptive Neuromodulation Digital Migraine Treatment Gains CE Mark
    Tekni-Plex Purchases Manufacturer Lameplast Tekni-Plex Purchases Manufacturer Lameplast
    AngioDynamics Enrolls First Patient in NanoKnife DIRECT Clinical Study AngioDynamics Enrolls First Patient in NanoKnife DIRECT Clinical Study
    New MDR and IVDR Tools Released to Help Medical Device, Diagnostics Firms Comply With EU Regulations New MDR and IVDR Tools Released to Help Medical Device, Diagnostics Firms Comply With EU Regulations
    Submicroscopic Spacecrafts: Graphene Flakes to Control Neuron Activity Submicroscopic Spacecrafts: Graphene Flakes to Control Neuron Activity
    Developing Market Access Strategies Developing Market Access Strategies
    ExThera Medical Creates Scientific Advisory Board ExThera Medical Creates Scientific Advisory Board
    Philips Releases Results of 3-Year Telehealth Study Affecting Over 100,000 European Patients Philips Releases Results of 3-Year Telehealth Study Affecting Over 100,000 European Patients

    Related Breaking News

    • NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite

      NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite

      Mobile Stroke Unit includes new CT scanner and features that help EMTs improve patient care.
      Michael Barbella, Managing Editor 04.19.21

    • IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System

      IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System

      Product has three programmable firing modes for tissue sampling.
      Michael Barbella, Managing Editor 04.19.21

    • Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development

      Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development

      Projects address infant feeding development, neonatal jaundice, pediatric dysphagia, unplanned extubations, and adrenal crisis.
      Michael Barbella, Managing Editor 04.19.21


    • Iterative Scopes Announces IBD-Focused Scientific Advisory Board

      Iterative Scopes Announces IBD-Focused Scientific Advisory Board

      The governing body also will include experts in artificial intelligence.
      Michael Barbella, Managing Editor 04.16.21

    • Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal

      Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal

      Transaction is expected to foster the development of Vicarious Surgical's flagship robot and establish a foundation for long-term growth.
      Michael Barbella, Managing Editor 04.16.21

    • Diagnostics
      FDA Grants De Novo Clearance to Medtronic’s GI Genius Model

      FDA Grants De Novo Clearance to Medtronic’s GI Genius Model

      Assists physicians in detecting pre-cancerous growths, potentially addressing 19 million colonoscopies annually.
      Charles Sternberg, Assistant Editor 04.15.21


    • Acutus Medical Receives FDA Clearance of AcQCross

      Acutus Medical Receives FDA Clearance of AcQCross

      Product family targets more than 300,000 annual U.S. electrophysiology and structural heart procedures.
      Michael Barbella, Managing Editor 04.15.21

    • Thermo Fisher Scientific to Acquire PPD for $17.4 Billion

      Thermo Fisher Scientific to Acquire PPD for $17.4 Billion

      The deal establishes Thermo Fisher as a global leader in the high-growth clinical research services industry.
      Michael Barbella, Managing Editor 04.15.21

    • Portable Medical Devices Market to Reach $100 Billion by 2027

      Portable Medical Devices Market to Reach $100 Billion by 2027

      Sector to grow 8.5 percent annually over the next six years, driven by an increased awareness of overall health and fitness.
      Michael Barbella, Managing Editor 04.15.21


    • Chronic Disease
      BD Receives 510(k) Clearance for Pristine Catheter

      BD Receives 510(k) Clearance for Pristine Catheter

      The clearance was supported by clinical data from a feasibility study with favorable primary patency rates observed out to 180 days.
      Charles Sternberg, Assistant Editor 04.15.21

    • Chronic Disease
      Medtronic Introduces Extended Infusion Set in Europe

      Medtronic Introduces Extended Infusion Set in Europe

      Can be worn for up to seven days so users can safely stay on insulin pump therapy with fewer interruptions and insertions.
      Charles Sternberg, Assistant Editor 04.14.21

    • Cardiovascular | Software & IT
      BioSig Launches Software Update for PURE EP Electrophysiology Platform

      BioSig Launches Software Update for PURE EP Electrophysiology Platform

      The upgrade includes enhanced signal processing for advanced cardiac signal analysis.
      Sam Brusco, Associate Editor 04.14.21


    • Surgical
      Katena Acquires Ophthalmic Surgical Instrument Maker ASICO

      Katena Acquires Ophthalmic Surgical Instrument Maker ASICO

      Katena obtains high-quality ophthalmic surgical instruments.
      Sam Brusco, Associate Editor 04.14.21

    • Vicarious Surgical Appoints CFO and Chief Legal Officer

      Vicarious Surgical Appoints CFO and Chief Legal Officer

      William J. Kelly and June M. Morris have joined the company's executive team.
      Michael Barbella, Managing Editor 04.14.21

    • Nagarro Achieves ISO 13485 Certification

      Nagarro Achieves ISO 13485 Certification

      Company's iife sciences and healthcare business unit offers new opportunities in digital disruption and connected medical devices.
      Michael Barbella, Managing Editor 04.14.21


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • Device Designed To Permanently Replace Failing Human Hearts
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite
    • IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System
    • Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development
    • Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    • Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    Coatings World

    Latest Breaking News From Coatings World

    Stahl Launches NuVera
    PPG Acquires Automotive Coatings Manufacturer Cetelon
    Jebsen & Jessen, Innospec Sign Distribution Agreement
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite
    IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System
    Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Resilience Acquires Ology Bioservices
    RDIF, Hualan Ink COVID-19 Vaccine Deal
    Kintor, Visum Enter COVID-19 Manufacturing Partnership
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Bésame Cosmetics Unveils Marilyn Monroe Collection
    Procos Opens U.S. Office
    Weekly Recap: HipDot Reese’s Makeup Collection, Cosmoprof Worldwide Bologna Postponed & More
    Happi

    Latest Breaking News From Happi

    Jergens Launches Mother’s Day Campaign
    Fragrance Creators Association Celebrates P&G Executive
    Jeen International Celebrates Its 25th Anniversary
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    ACTEGA helps converter reach sustainability goals
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Andritz to Supply Elliptical Cylinder Pre-Needler in France
    Ahlstrom-Munksjö to be Delisted from Nasdaq Stockholm
    Radienz Living Introduces Sustainable Products
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    First Surgeries Completed With Globus Medical's CREO ONE Robotic Screw
    BioMagnetic Sciences Names President and CEO
    Mainstay Medical Launches ReActiv8 in Australia
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    LG Display Cuts Down CO2-eq Emissions by 3 Million Tons in 2020
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login